NEXENTIS TECHNOLOGIES INC. Total Long-Term Debt
NEXENTIS TECHNOLOGIES INC. (NXTS) had Total Long-Term Debt of $8.39 thousand as of 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2022-03-31
- 2021-12-31: Long-term Debt $8.39K.
- 2020-12-31: Long-term Debt $16.06K.
- 2019-12-31: Long-term Debt $22.18K.
- 2018-12-31: Long-term Debt $60.80K.
| Period end | Long-term Debt |
|---|---|
| 2021-12-31 | $8.39K 10-K · filed 2022-03-31 |
| 2020-12-31 | $16.06K 10-K · filed 2022-03-31 |
| 2019-12-31 | $22.18K 10-K · filed 2021-03-29 |
| 2018-12-31 | $60.80K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |